Cargando…

Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women

BACKGROUND/OBJECTIVES: Women are ubiquitously exposed to endocrine disruptors, including phthalates. Ovarian follicles undergoing folliculogenesis (indirectly measured by ovarian volume) produce anti-Müllerian hormone (AMH) and estradiol (E2). We evaluated associations of phthalates with ovarian vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinzori, Maria E., Pacyga, Diana C., Babayev, Elnur, Duncan, Francesca E., Li, Zhong, Williams, Paige L., Flaws, Jodi A., Strakovsky, Rita S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012419/
https://www.ncbi.nlm.nih.gov/pubmed/36724714
http://dx.doi.org/10.1016/j.envint.2023.107771
_version_ 1784906602147479552
author Cinzori, Maria E.
Pacyga, Diana C.
Babayev, Elnur
Duncan, Francesca E.
Li, Zhong
Williams, Paige L.
Flaws, Jodi A.
Strakovsky, Rita S.
author_facet Cinzori, Maria E.
Pacyga, Diana C.
Babayev, Elnur
Duncan, Francesca E.
Li, Zhong
Williams, Paige L.
Flaws, Jodi A.
Strakovsky, Rita S.
author_sort Cinzori, Maria E.
collection PubMed
description BACKGROUND/OBJECTIVES: Women are ubiquitously exposed to endocrine disruptors, including phthalates. Ovarian follicles undergoing folliculogenesis (indirectly measured by ovarian volume) produce anti-Müllerian hormone (AMH) and estradiol (E2). We evaluated associations of phthalates with ovarian volume to assess whether this explained prior positive associations of phthalates with AMH and E2. METHODS: Women ages 45–54 years (n = 614) had transvaginal ultrasounds of right/left ovaries to calculate mean ovarian volume. Women provided up-to-four urine and blood samples for quantifying AMH (first serum sample), E2 (all serum samples), and nine phthalate metabolites (from pooled urine, representing six parent phthalates). Multivariable linear or logistic regression models (for individual phthalate biomarkers), as well as weighted quantile sum (WQS) regression (for mixture analyses) evaluated associations of phthalate biomarkers with ovarian volume. Using cross-sectional mediation analysis, we assessed whether associations of phthalates with ovarian volume partially explained those of phthalates with AMH or E2. RESULTS: Most women were non-Hispanic White (68%) and pre-menopausal (67%) with higher urinary phthalate metabolite concentrations than U.S. women. In single-pollutant models, 10% increases in mono(3-earboxypropyl) phthalate (MCPP) and monobenzyl phthalate (MBzP) were associated with 0.44% (95% CI: −0.02%, 0.91%) and 0.62% (95% CI: 0.02%, 1.23%) larger ovarian volumes, respectively. As a cumulative mixture, 10% increases in the phthalate mixture were associated with 2.89% larger ovarian volume (95%CI: 0.27, 5.59) with MCPP (35%) and MBzP (41%) identified as major contributors. Higher ovarian volume due to a 10% increase in MBzP (indirect effect OR: 1.004; 95% CI: 1.00, 1.01) explained 16% of the positive association between MBzP and higher AMH, whereas higher ovarian volume due to a 10% increase in MCPP (indirect effect %Δ: 0.11; 95% CI: −0.01, 0.22) explained 23% of the positive association between MCPP and E2. CONCLUSION: In this cross-sectional study, phthalates were associated with increased ovarian volume, with implications for midlife hormone production.
format Online
Article
Text
id pubmed-10012419
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-100124192023-03-14 Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women Cinzori, Maria E. Pacyga, Diana C. Babayev, Elnur Duncan, Francesca E. Li, Zhong Williams, Paige L. Flaws, Jodi A. Strakovsky, Rita S. Environ Int Article BACKGROUND/OBJECTIVES: Women are ubiquitously exposed to endocrine disruptors, including phthalates. Ovarian follicles undergoing folliculogenesis (indirectly measured by ovarian volume) produce anti-Müllerian hormone (AMH) and estradiol (E2). We evaluated associations of phthalates with ovarian volume to assess whether this explained prior positive associations of phthalates with AMH and E2. METHODS: Women ages 45–54 years (n = 614) had transvaginal ultrasounds of right/left ovaries to calculate mean ovarian volume. Women provided up-to-four urine and blood samples for quantifying AMH (first serum sample), E2 (all serum samples), and nine phthalate metabolites (from pooled urine, representing six parent phthalates). Multivariable linear or logistic regression models (for individual phthalate biomarkers), as well as weighted quantile sum (WQS) regression (for mixture analyses) evaluated associations of phthalate biomarkers with ovarian volume. Using cross-sectional mediation analysis, we assessed whether associations of phthalates with ovarian volume partially explained those of phthalates with AMH or E2. RESULTS: Most women were non-Hispanic White (68%) and pre-menopausal (67%) with higher urinary phthalate metabolite concentrations than U.S. women. In single-pollutant models, 10% increases in mono(3-earboxypropyl) phthalate (MCPP) and monobenzyl phthalate (MBzP) were associated with 0.44% (95% CI: −0.02%, 0.91%) and 0.62% (95% CI: 0.02%, 1.23%) larger ovarian volumes, respectively. As a cumulative mixture, 10% increases in the phthalate mixture were associated with 2.89% larger ovarian volume (95%CI: 0.27, 5.59) with MCPP (35%) and MBzP (41%) identified as major contributors. Higher ovarian volume due to a 10% increase in MBzP (indirect effect OR: 1.004; 95% CI: 1.00, 1.01) explained 16% of the positive association between MBzP and higher AMH, whereas higher ovarian volume due to a 10% increase in MCPP (indirect effect %Δ: 0.11; 95% CI: −0.01, 0.22) explained 23% of the positive association between MCPP and E2. CONCLUSION: In this cross-sectional study, phthalates were associated with increased ovarian volume, with implications for midlife hormone production. 2023-02 2023-01-24 /pmc/articles/PMC10012419/ /pubmed/36724714 http://dx.doi.org/10.1016/j.envint.2023.107771 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Cinzori, Maria E.
Pacyga, Diana C.
Babayev, Elnur
Duncan, Francesca E.
Li, Zhong
Williams, Paige L.
Flaws, Jodi A.
Strakovsky, Rita S.
Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title_full Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title_fullStr Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title_full_unstemmed Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title_short Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women
title_sort ovarian volume partially explains associations of phthalate biomarkers with anti-müllerian hormone and estradiol in midlife women
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012419/
https://www.ncbi.nlm.nih.gov/pubmed/36724714
http://dx.doi.org/10.1016/j.envint.2023.107771
work_keys_str_mv AT cinzorimariae ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT pacygadianac ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT babayevelnur ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT duncanfrancescae ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT lizhong ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT williamspaigel ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT flawsjodia ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen
AT strakovskyritas ovarianvolumepartiallyexplainsassociationsofphthalatebiomarkerswithantimullerianhormoneandestradiolinmidlifewomen